Synopsis "We have grown by more than 30% in the last two years. We think that going forward we can also contribute to a large extent for the growth of this country in the healthcare space and we are very much bullish on our business and about healthcare. A 10% increase in price will not affect even 2% on our top line. " Related Saurabh Mukherjea on why he is excited about midcap lenders & bought this newly listed company Tarsons Products' debt will be almost zero post IPO: Rohan Sehgal Tarson Products to use IPO proceeds for repaying debt and expansion: Rohan Sehgal "Total labware Indian market is Rs 1,200 crore but our addressable market currently is only Rs 650 crore. Out of this Rs 650 crore, we hold 25% and we are also entering into cell cultures and PCR. Now we will also address the remaining Rs 650 crore. So going forward, we will be able to maintain the 25% share in the overall Rs 1,200-crore market," says Santosh Agarwal , CFO & Company Secretary, Tarsons Products . What does the company really do? What are the growth visibility and prospects looking like? I understand there are significant… Read full this story
- Cover Story: Hiap Teck’s RM3 bil expansion plans for Eastern Steel
- KFC, Pizza Hut operator Sapphire CFO eyes both organic and inorganic growth after IPO
- Retailers on expansion drive as sales return to pre-pandemic levels
- Tarsons Products IPO opens today: Here's what brokerages are recommending
- Tarsons Products’ debt will be almost zero post IPO: Rohan Sehgal
- Tarsons Products IPO sees 77.49 times subscription on final day of bidding
- STL CFO says US, UK expansion top focus, big bang M&A not on cards
- Tarsons Products shares debut: Could the listing premium justify the investor interest?
- Inflation is impacting demand in Q3, but expecting reasonable festive quarter: SKF India CFO
- PB Fintech chases growth, does not burn cash to get it: CFO Alok Bansal
Tarsons CFO on growth, expansion plans & export prospects have 311 words, post on economictimes.indiatimes.com at March 24, 2022. This is cached page on xBlogs. If you want remove this page, please contact us.